{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:36:06Z","timestamp":1794634566425,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The research was funded by a grant of the University of Torino"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Depression is a mental illness characterized by despair behavior, inability to feel pleasure, and social withdrawal. Causes are not yet clarified, but stress is a condition that induces depression. Neuronal alterations, comprising maladaptive neuronal plasticity and excitability, are present in both responses to stress and depression. Fibroblast growth factor 14 (<jats:italic>Fgf14<\/jats:italic>) controls neuronal excitability and proper action potential firing by stabilizing voltage-dependent sodium (Na<jats:sub>v<\/jats:sub>) channels into the axon. <jats:italic>Fgf14<\/jats:italic>-Na<jats:sub>v<\/jats:sub> channels complex is regulated by glycogen synthase kinase 3. Recently, <jats:italic>Fgf14<\/jats:italic> has been genetically associated to depression. However, little is known about its role in controlling stress-induced depression. This study demonstrates that female <jats:italic>Fgf14<\/jats:italic>\n            <jats:sup>\n              <jats:italic>\u2212\/\u2212<\/jats:italic>\n            <\/jats:sup> mice are resilient to depression, as reported by reduced level of despair behavior, <jats:italic>anhedonia<\/jats:italic>, and increased sociability. Also, a reduction of anxious-like behavior was highlighted. <jats:italic>Fgf14<\/jats:italic>\n            <jats:sup>\n              <jats:italic>\u2212\/\u2212<\/jats:italic>\n            <\/jats:sup> mice showed increased expression of cannabinoid receptor without alterations of dopaminergic system in mPFC, suggesting a link between <jats:italic>Fgf14<\/jats:italic> and endocannabinoid system in the control mechanisms underlying depression. Neuronal activity was assessed by analyzing cFOS expression during basal and following acute stress induced by tail suspension test (TST). The analysis revealed that neuronal activation in mPFC and VTA was correlated to immobility, where ratio of cFOS expression over immobility was significantly higher in <jats:italic>Fgf14<\/jats:italic>\n            <jats:sup>\n              <jats:italic>\u2212\/\u2212<\/jats:italic>\n            <\/jats:sup> mice. This suggests that higher neuronal activity might be involved in resilience to depression. In resilient <jats:italic>Fgf14<\/jats:italic>\n            <jats:sup>\n              <jats:italic>\u2212\/\u2212<\/jats:italic>\n            <\/jats:sup> mice, TST-induced acute stress caused activation only in pyramidal neurons. Our findings suggest that <jats:italic>Fgf14<\/jats:italic> is involved in stress-coping mechanisms and could be targeted to improve resilience to depression.<\/jats:p>","DOI":"10.1038\/s41398-025-03361-z","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T22:47:36Z","timestamp":1744238856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Deletion of Fgf14 confers resilience to basal and stress-induced depressive-like behavior and reduces anxiety in mice"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3633-8746","authenticated-orcid":false,"given":"Francesca","family":"Montarolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6621-620X","authenticated-orcid":false,"given":"Anita Maria","family":"Rominto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2764-4909","authenticated-orcid":false,"given":"Luna","family":"Berrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7052-1907","authenticated-orcid":false,"given":"Antonio","family":"Bertolotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1141-1852","authenticated-orcid":false,"given":"Fernanda","family":"Laezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Tempia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4452-889X","authenticated-orcid":false,"given":"Eriola","family":"Hoxha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"3361_CR1","doi-asserted-by":"publisher","first-page":"104285.","DOI":"10.1016\/j.actpsy.2024.104285","volume":"246","author":"L Spytska","year":"2024","unstructured":"Spytska L. Anxiety and depressive personality disorders in the modern world. Acta Psychol (Amst). 2024;246:104285.","journal-title":"Acta Psychol (Amst)"},{"key":"3361_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpsyt.2018.00323","volume":"9","author":"Z Zuo","year":"2018","unstructured":"Zuo Z, Ran S, Wang Y, Li C, Han Q, Tang Q, et al. Altered structural covariance among the dorsolateral prefrontal cortex and amygdala in treatment-Na\u00efve patients with major depressive disorder. Front Psychiatry. 2018;9:1\u201310.","journal-title":"Front Psychiatry"},{"key":"3361_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2022.103396","volume":"80","author":"Q Luo","year":"2023","unstructured":"Luo Q, Chen J, Li Y, Lin X, Yu H, Lin X, et al. Cortical thickness and curvature abnormalities in patients with major depressive disorder with childhood maltreatment: neural markers of vulnerability? Asian J Psychiatr. 2023;80:103396.","journal-title":"Asian J Psychiatr"},{"key":"3361_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/da.22227","volume":"31","author":"RS Duman","year":"2014","unstructured":"Duman RS. Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections. Depress Anxiety. 2014;31:291\u20136.","journal-title":"Depress Anxiety"},{"key":"3361_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ynstr.2017.05.001","volume":"7","author":"KG Bath","year":"2017","unstructured":"Bath KG, Russo SJ, Pleil KE, Wohleb ES, Duman RS, Radley JJ. Circuit and synaptic mechanisms of repeated stress: perspectives from differing contexts, duration, and development. Neurobiol Stress. 2017;7:137\u201351.","journal-title":"Neurobiol Stress"},{"key":"3361_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnbeh.2018.00127","volume":"12","author":"LD Godoy","year":"2018","unstructured":"Godoy LD, Rossignoli MT, Delfino-Pereira P, Garcia-Cairasco N, Umeoka EH, de L. A comprehensive overview on stress neurobiology: basic concepts and clinical implications. Front Behav Neurosci. 2018;12:1\u201323.","journal-title":"Front Behav Neurosci"},{"key":"3361_CR7","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1007\/s00018-015-2044-6","volume":"72","author":"C Dipesh","year":"2015","unstructured":"Dipesh C, He L, Ming-Hu H. Neuronal correlates of depression. Cell Mol Life Sci. 2015;72:4825\u201348.","journal-title":"Cell Mol Life Sci"},{"key":"3361_CR8","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/ijnp\/pyx056","volume":"20","author":"P Belujon","year":"2017","unstructured":"Belujon P, Grace AA. Dopamine system dysregulation in major depressive disorders. Int J Neuropsychopharmacol. 2017;20:1036\u201346.","journal-title":"Int J Neuropsychopharmacol"},{"key":"3361_CR9","doi-asserted-by":"publisher","first-page":"5526","DOI":"10.3390\/ijms23105526","volume":"23","author":"U Bright","year":"2022","unstructured":"Bright U, Akirav I. Modulation of endocannabinoid system components in depression: pre-clinical and clinical evidence. Int J Mol Sci. 2022;23:5526.","journal-title":"Int J Mol Sci"},{"key":"3361_CR10","first-page":"605","volume":"30","author":"J Amol","year":"2018","unstructured":"Amol J. Selective serotonin re-uptake inhibitors: an overview. Psychiatr Danub. 2018;30:605\u20139.","journal-title":"Psychiatr Danub"},{"key":"3361_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/hup.2424","volume":"29","author":"SA Montgomery","year":"2014","unstructured":"Montgomery SA, Nielsen RZ, Poulsen LH, H\u00e4ggstr\u00f6m L. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin\u2013noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelat. Hum Psychopharmacol Clin Exp. 2014;29:470\u201382.","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"3361_CR12","doi-asserted-by":"publisher","first-page":"e41778","DOI":"10.1371\/journal.pone.0041778","volume":"7","author":"A Khan","year":"2012","unstructured":"Khan A, Faucett J, Lichtenberg P, Kirsch I, Brown WA. A systematic review of comparative efficacy of treatments and controls for depression. Plos ONE. 2012;7:e41778.","journal-title":"Plos ONE"},{"key":"3361_CR13","first-page":"16","volume":"6","author":"E Cascade","year":"2009","unstructured":"Cascade E, Kalali AH, Kennedy SH. Real-world data on SSRI antidepressant side effects. Psychiatry. 2009;6:16.","journal-title":"Psychiatry"},{"key":"3361_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nn2040","volume":"11","author":"MH Kole","year":"2008","unstructured":"Kole MH, Ilschner SU, Kampa BM, Williams SR, Ruben PC, Stuart GJ. Action potential generation requires a high sodium channel density in the axon initial segment. Nat Neurosci. 2008;11:178\u201386.","journal-title":"Nat Neurosci"},{"key":"3361_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/bs.ctm.2015.10.005","volume":"77","author":"C Leterrier","year":"2016","unstructured":"Leterrier C. The axon initial segment, 50 years later: a nexus for neuronal organization and function. Curr Top Membr. 2016;77:185\u2013233.","journal-title":"Curr Top Membr"},{"key":"3361_CR16","unstructured":"Wittmack E, Rush A, Craner M, Goldfarb M, Waxman S, Dib-Hajj S. Fibroblast growth factor homologous factor 2B: association with Nav1.6 and selective colocalization at nodes of ranvier of dorsal root axons."},{"key":"3361_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1113\/jphysiol.2005.097220","volume":"569","author":"JY Lou","year":"2005","unstructured":"Lou JY, Laezza F, Gerber BR, Xiao M, Yamada KA, Hartmann H, et al. Fibroblast growth factor 14 is an intracellular modulator of voltage-gated sodium channels. J Physiol. 2005;569:179\u201393.","journal-title":"J Physiol"},{"key":"3361_CR18","doi-asserted-by":"publisher","first-page":"12033","DOI":"10.1523\/JNEUROSCI.2282-07.2007","volume":"27","author":"F Laezza","year":"2007","unstructured":"Laezza F, Gerber BR, Lou JY, Kozel MA, Hartman H, Craig AM, et al. The FGF14F145S mutation disrupts the interaction of FGF14 with voltage-gated Na+ channels and impairs neuronal excitability. J Neurosci. 2007;27:12033\u201344.","journal-title":"J Neurosci"},{"key":"3361_CR19","first-page":"1","volume":"23","author":"F Laezza","year":"2008","unstructured":"Laezza F, Lampert A, Koze MA, Gerber B, Rush A, Nerbonne J, et al. FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. Bone. 2008;23:1\u20137.","journal-title":"Bone"},{"key":"3361_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55554-7","volume":"16","author":"NM Dvorak","year":"2025","unstructured":"Dvorak NM, Wadsworth PA, Aquino-Miranda G, Wang P, Engelke DS, Zhou J, et al. Enhanced motivated behavior mediated by pharmacological targeting of the FGF14\/Nav1.6\u2009complex in nucleus accumbens neurons. Nat Commun. 2025;16:110.","journal-title":"Nat Commun"},{"key":"3361_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0925-4773(99)00241-5","volume":"90","author":"Q Wang","year":"2000","unstructured":"Wang Q, McEwen DG, Ornitz DM. Subcellular and developmental expression of alternatively spliced forms of fibroblast growth factor 14. Mech Dev. 2000;90:283\u20137.","journal-title":"Mech Dev"},{"key":"3361_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1086\/345488","volume":"72","author":"JC Van Swieten","year":"2003","unstructured":"Van Swieten JC, Brusse E, De Graaf BM, Krieger E, Van de Graaf R, De Koning I, et al. A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebral ataxia. Am J Hum Genet. 2003;72:191\u20139.","journal-title":"Am J Hum Genet"},{"key":"3361_CR23","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/mds.20708","volume":"21","author":"E Brusse","year":"2006","unstructured":"Brusse E, de Koning I, Maat-Kievit A, Oostra BA, Heutink P, van Swieten JC. Spinocerebellar ataxia associated with a mutation in the fibroblast growth factor 14 gene (SCA27): a new phenotype. Mov Disord. 2006;21:396\u2013401.","journal-title":"Mov Disord"},{"key":"3361_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2015.00205","volume":"9","author":"F Tempia","year":"2015","unstructured":"Tempia F, Hoxha E, Negro G, Alshammari MA, Alshammari TK, Panova-Elektronova N, et al. Parallel fiber to purkinje cell synaptic impairment in a mouse model of spinocerebellar ataxia type 27. Front Cell Neurosci. 2015;9:1\u201310.","journal-title":"Front Cell Neurosci"},{"key":"3361_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02992-7","volume":"20","author":"NM Dvorak","year":"2023","unstructured":"Dvorak NM, Domingo ND, Tapia CM, Wadsworth PA, Marosi M, Avchalumov Y, et al. TNFR1 signaling converging on FGF14 controls neuronal hyperactivity and sickness behavior in experimental cerebral malaria. J Neuroinflammation. 2023;20:306.","journal-title":"J Neuroinflammation"},{"key":"3361_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0896-6273(02)00744-4","volume":"35","author":"Q Wang","year":"2002","unstructured":"Wang Q, Bardgett ME, Wong M, Wozniak DF, Lou J, McNeil BD, et al. Ataxia and paroxysmal dyskinesia in mice lacking axonally transported FGF14. Neuron. 2002;35:25\u201338.","journal-title":"Neuron"},{"key":"3361_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.neuron.2007.07.006","volume":"55","author":"M Goldfarb","year":"2007","unstructured":"Goldfarb M, Schoorlemmer J, Williams A, Diwakar S, Wang Q, Huang X, et al. Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels. Neuron. 2007;55:449\u201363.","journal-title":"Neuron"},{"key":"3361_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.bbr.2018.08.034","volume":"356","author":"A Marcinn\u00f2","year":"2019","unstructured":"Marcinn\u00f2 A, Montarolo F, Masante L, Balbo I. Emerging roles of Fgf14 in behavioral control. Behav Brain Res. 2019;356:257\u201365.","journal-title":"Behav Brain Res"},{"key":"3361_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.66","volume":"6","author":"TK Alshammari","year":"2016","unstructured":"Alshammari TK, Alshammari MA, Nenov MN, Hoxha E, Cambiaghi M, Marcinno A, et al. Genetic deletion of fibroblast growth factor 14 recapitulates phenotypic alterations underlying cognitive impairment associated with schizophrenia. Transl Psychiatry. 2016;6:e806.","journal-title":"Transl Psychiatry"},{"key":"3361_CR30","doi-asserted-by":"publisher","first-page":"e37384","DOI":"10.1371\/journal.pone.0037384","volume":"7","author":"EC Verbeek","year":"2012","unstructured":"Verbeek EC, Bakker IMC, Bevova MR, Bochdanovits Z, Rizzu P, Sondervan D, et al. A fine-mapping study of 7 top scoring genes from a GWAS for major depressive disorder. PLoS ONE. 2012;7:e37384.","journal-title":"PLoS ONE"},{"key":"3361_CR31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.gene.2015.07.007","volume":"572","author":"HN Singh","year":"2015","unstructured":"Singh HN, Rajeswari MR. Role of long purine stretches in controlling the expression of genes associated with neurological disorders. Gene. 2015;572:175\u201383.","journal-title":"Gene"},{"key":"3361_CR32","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1073\/pnas.96.10.5604","volume":"96","author":"SD Detera-Wadleigh","year":"1999","unstructured":"Detera-Wadleigh SD, Badner JA, Berrettini WH, Yoshikawa T, Goldin LR, Turner G, et al. A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci USA. 1999;96:560.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3361_CR33","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1096\/fj.201500161","volume":"30","author":"WCJ Hsu","year":"2016","unstructured":"Hsu WCJ, Scala F, Nenov MN, Wildburger NC, Elferink H, Singh AK, et al. CK2 Activity is required for the interaction of FGF14 with voltage-gated sodium channels and neuronal excitability. FASEB J. 2016;30:2171\u201386.","journal-title":"FASEB J"},{"key":"3361_CR34","doi-asserted-by":"publisher","first-page":"e0117246","DOI":"10.1371\/journal.pone.0117246","volume":"10","author":"W-C Hsu","year":"2015","unstructured":"Hsu W-C, Nenov MN, Shavkunov A, Panova N, Zhan M, Laezza F. Identifying a kinase network regulating FGF14:Nav1.6 complex assembly using split-luciferase complementation. PLoS ONE. 2015;10:e0117246.","journal-title":"PLoS ONE"},{"key":"3361_CR35","doi-asserted-by":"publisher","first-page":"19370","DOI":"10.1074\/jbc.M112.445924","volume":"288","author":"AS Shavkunov","year":"2013","unstructured":"Shavkunov AS, Wildburger NC, Nenov MN, James TF, Buzhdygan TP, Panova-Elektronova NI, et al. The fibroblast growth factor 14\u00b7voltage-gated sodium channel complex is a new target of glycogen synthase kinase 3 (GSK3). J Biol Chem. 2013;288:19370\u201385.","journal-title":"J Biol Chem"},{"key":"3361_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnmol.2012.00080","volume":"5","author":"NC Wildburger","year":"2012","unstructured":"Wildburger NC, Laezza F. Control of neuronal ion channel function by glycogen synthase kinase-3: new prospective for an old kinase. Front Mol Neurosci. 2012;5:80.","journal-title":"Front Mol Neurosci"},{"key":"3361_CR37","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.celrep.2018.03.062","volume":"23","author":"F Scala","year":"2018","unstructured":"Scala F, Nenov MN, Crofton EJ, Singh AK, Folorunso O, Zhang Y, et al. Environmental enrichment and social isolation mediate neuroplasticity of medium spiny neurons through the GSK3 pathway. Cell Rep. 2018;23:555\u201367.","journal-title":"Cell Rep"},{"key":"3361_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-023-00314-7","volume":"11","author":"G Rosso","year":"2023","unstructured":"Rosso G, Maina G, Teobaldi E, Balbo I, Di Salvo G, Montarolo F, et al. Differential diagnosis of unipolar versus bipolar depression by GSK3 levels in peripheral blood: a pilot experimental study. Int J Bipolar Disord. 2023;11:33.","journal-title":"Int J Bipolar Disord"},{"key":"3361_CR39","doi-asserted-by":"publisher","first-page":"e729","DOI":"10.1016\/S2468-2667(21)00047-5","volume":"6","author":"J Arias-de la Torre","year":"2021","unstructured":"Arias-de la Torre J, Vilagut G, Ronaldson A, Serrano-Blanco A, Mart\u00edn V, Peters M, et al. Prevalence and variability of current depressive disorder in 27 European countries: a population-based study. Lancet Public Health. 2021;6:e729\u201338.","journal-title":"Lancet Public Health"},{"key":"3361_CR40","doi-asserted-by":"publisher","unstructured":"Can A, Dao DT, Terrillion CE, Piantadosi SC, Bhat S, Gould TD. The tail suspension test. J Vis Exp. 2012;e3769 https:\/\/doi.org\/10.3791\/3769.","DOI":"10.3791\/3769"},{"key":"3361_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-019-0544-0","volume":"9","author":"F Montarolo","year":"2019","unstructured":"Montarolo F, Martire S, Perga S, Spadaro M, Brescia I, Allegra S, et al. NURR1 deficiency is associated to ADHD-like phenotypes in mice. Transl Psychiatry. 2019;9:207 https:\/\/doi.org\/10.1038\/s41398-019-0544-0.","journal-title":"Transl Psychiatry"},{"key":"3361_CR42","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1002\/jnr.25067","volume":"100","author":"F Montarolo","year":"2022","unstructured":"Montarolo F, Martire S, Chiara F, Allegra S, De Francia S, Hoxha E, et al. NURR1-deficient mice have age- and sex-specific behavioral phenotypes. J Neurosci Res. 2022;100:1747\u201354.","journal-title":"J Neurosci Res"},{"key":"3361_CR43","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/glia.23448","volume":"66","author":"V Cerrato","year":"2018","unstructured":"Cerrato V, Mercurio S, Leto K, Fuc\u00e0 E, Hoxha E, Bottes S, et al. Sox2 conditional mutation in mouse causes ataxic symptoms, cerebellar vermis hypoplasia, and postnatal defects of Bergmann glia. Glia. 2018;66:1929\u201346.","journal-title":"Glia"},{"key":"3361_CR44","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1002\/glia.24048","volume":"69","author":"E Hoxha","year":"2021","unstructured":"Hoxha E, Balbo I, Parolisi R, Audano M, Montarolo F, Ravera F, et al. Elovl5 is required for proper action potential conduction along peripheral myelinated fibers. Glia. 2021;69:2419\u201328.","journal-title":"Glia"},{"key":"3361_CR45","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Earlbaum Associates; 1988.","edition":"2nd ed."},{"key":"3361_CR46","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3390\/neurosci3040050","volume":"3","author":"SY Lara Aparicio","year":"2022","unstructured":"Lara Aparicio SY, Laureani Fierro \u00c1J, Aranda Abreu GE, Toledo C\u00e1rdenas R, Garc\u00eda Hern\u00e1ndez LI, Coria \u00c1vila GA, et al. Current opinion on the use of c-Fos in neuroscience. NeuroSci. 2022;3:687\u2013702.","journal-title":"NeuroSci"},{"key":"3361_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.nbd.2006.11.014","volume":"26","author":"DF Wozniak","year":"2007","unstructured":"Wozniak DF, Xiao M, Xu L, Yamada KAOD. Impaired spatial learning and defective theta burst induced LTP in mice lacking fibroblast growth factor 14. Neurobiol Dis. 2007;26:14\u201326.","journal-title":"Neurobiol Dis"},{"key":"3361_CR48","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.3390\/ijms23084413","volume":"23","author":"M Marosi","year":"2022","unstructured":"Marosi M, Arman P, Aceto G, D\u2019Ascenzo M, Laezza F. Glycogen synthase kinase 3: ion channels, plasticity, and diseases. Int J Mol Sci. 2022;23:4413.","journal-title":"Int J Mol Sci"},{"key":"3361_CR49","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3390\/cells9051110","volume":"9","author":"P Duda","year":"2020","unstructured":"Duda P, Akula SM, Abrams SL, Steelman LS, Martelli AM, Cocco L, et al. Targeting GSK3 and associated signaling pathways involved in cancer. Cells. 2020;9:1110.","journal-title":"Cells"},{"key":"3361_CR50","first-page":"1","volume":"23","author":"MN Hill","year":"2008","unstructured":"Hill MN, Ho WS, Hillard CJ, Gorzalka BB. Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents. Bone. 2008;23:1\u20137.","journal-title":"Bone"},{"key":"3361_CR51","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1124\/mol.109.060079","volume":"77","author":"S Mato","year":"2010","unstructured":"Mato S, Vidal R, Castro E, Diaz A, Pazos A, Valdizan EM. Long-term fluoxetine treatment modulates cannabinoid type 1 receptor-mediated inhibition of adenylyl cyclase in the rat prefrontal cortex through 5-hydroxytryptamine 1A receptor- dependent mechanisms. Mol Pharmacol. 2010;77:424\u201334.","journal-title":"Mol Pharmacol"},{"key":"3361_CR52","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2174\/1570159X11311030003","volume":"11","author":"MV Fogaca","year":"2013","unstructured":"Fogaca MV, Galve-Roperh I, Guimaraes FS, Campos AC. Cannabinoids, neurogenesis and antidepressant drugs: is there a link? Curr Neuropharmacol. 2013;11:263\u201375.","journal-title":"Curr Neuropharmacol"},{"key":"3361_CR53","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0306-4522(03)00367-1","volume":"121","author":"C Westenbroek","year":"2003","unstructured":"Westenbroek C, Den Boer JA. Gender-specific effects of social housing on chronic stress-induced limbic Fos expression. Comp Study Neurosci. 2003;121:189\u201399.","journal-title":"Comp Study Neurosci"},{"key":"3361_CR54","first-page":"389","volume":"73","author":"C Hill","year":"2016","unstructured":"Hill C, Jain A, Takemoto H, Silver MD, Nagesh SVS, Ionita CN, et al. Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior. Science. 2016;73:389\u2013400.","journal-title":"Science"},{"key":"3361_CR55","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1523\/JNEUROSCI.0092-12.2013","volume":"33","author":"S Kumar","year":"2013","unstructured":"Kumar S, Black SJ, Hultman R, Szabo ST, Demaio KD, Du J, et al. Cortical control of affective networks. J Neurosci. 2013;33:1116\u201329.","journal-title":"J Neurosci"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03361-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03361-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03361-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T23:03:49Z","timestamp":1744239829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03361-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3361"],"URL":"https:\/\/doi.org\/10.1038\/s41398-025-03361-z","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}